Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
16122791 | NSC697923 | 343351-67-7 | 98% | |
NSC697923 is a cell-permeable and selective inhibitor of the Ub-conjugating enzyme (E | ||||
16122789 | NVP-CGM097 | 1313363-54-0 | 98% | |
NVP-CGM097 is a highly potent and selective MDM2 inhibitor. It binds to the p53 bindi | ||||
16122779 | NSC228155 | 113104-25-9 | 98% | |
NSC228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and mo | ||||
16122772 | NQDI-1 | 175026-96-7 | 98% | |
NQDI 1, an inhibitor of ASK1(apoptosis signal-regulating kinase 1), attenuates acute | ||||
16122719 | Nitroxoline | 4008-48-4 | 98% | |
Nitroxoline is a urinary antibacterial agent active against susceptible gram-positive | ||||
16122708 | Napabucasin | 83280-65-3 | 98% | |
Napabucasin is an orally available Stat3 and cancer cell stemness inhibitor.Napabucas | ||||
6111508 | Necrosulfonamide | 1360614-48-7 | 98% | |
Necrosulfonamide is a very specific and potent necrosis inhibitor and blocks mixed li | ||||
6111412 | Necrostatin 2 S enantiomer | 852391-20-9 | 98% | |
Necrostatin 2 is a potent necroptosis inhibitor with EC50 of 50 nM.Necrostatin 2 is a | ||||
6111411 | Necrostatin 2 racemate | 852391-15-2 | 98% | |
Necrostatin 2 is a potent necroptosis inhibitor with EC50 of 50 nM.Necrostatin 2 is a | ||||
6111112 | NBI-74330 | 855527-92-3 | 98% | |
NBI-74330 is a small molecule antagonist for CXCR3, NBI-74330 demonstrates potent inh | ||||
6111110 | Nastorazepide | 209219-38-5 | 98% | |
Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative | ||||
611923 | NU6300 | 98% | ||
NU6300 is a non-covalent ATP-competitive CDK2 inhibitor (IC50 = 0.16 mM). NU6300 | ||||
6118017 | NU 7026 | 154447-35-5 | 98% | |
NU 7026 is a novel and potential inhibitor of the DNA repair enzyme DNA-dependent pro | ||||
161014001 | NMS-859 | 1449236-96-7 | 98% by HPLC | |
NMS-859 is a potent and specific small molecule covalent inhibitor of the ATPase VCP/ | ||||
16071414 | NCT-501 | 1802088-50-1 | 98% by HPLC | |
NCT-501 is a potent ALDH1A1 inhibitor. Aldehyde dehydrogenases (ALDHs) metabolize rea | ||||
16071107 | Naquotinib | 448232-80-1 | 98% by HPLC | |
Naquotinib, also known as ASP8273, is an orally available, irreversible, third-genera | ||||
16070914 | Necrostatin 2 | 852391-19-6 | 98% by HPLC | |
Necrostatin 2 | ||||
16070102 | Navitoclax (ABT-263) | 923564-51-6 | 98% by HPLC | |
Navitoclax, also known as ABT-263, is an orally bioavailable, synthetic small-molecul | ||||
16060601 | NSC5844 | 140926-75-6 | 98% by HPLC | |
NSC5844 | ||||
032515 | NU2058 | 161058-83-9 | 98% | |
Coming soon! | ||||
012007 | NIBR189 | 1599432-08-2 | 98% | |
NIBR189 is a small molecule antagonist of the Epstein-Barr virus-induced gene 2 (EBI2 | ||||
011118 | NS6180 | 353262-04-1 | 98% | |
NS6180 is a novel potent and selective KCa3.1 channel inhibitor(IC50= 9 nM) prevents | ||||
010432 | NVP-ACC-789 | 300842-64-2 | 98% | |
Coming soon! | ||||
010408 | NVP-TNKS656 | 1419949-20-4 | 98% | |
NVP-TNKS656 is a highly potent, selective, and orally active TNKS2 inhibitor with IC5 | ||||
010404 | Nelarabine | 121032-29-9 | 98% | |
Nelarabine is a Nucleoside Metabolic Inhibitor. The mechanism of action of nelarabine | ||||
122901 | Nilotinib HCl hydrate | 923288-90-8 | 98% | |
Nilotinib is an orally bioavailable aminopyrimidine-derivative Bcr-Abl tyrosine kinas | ||||
122833 | NVP 231 | 362003-83-6 | 98% | |
NVP-231 is a potent, specific, and reversible CerK inhibitor(IC50=122 nM) that compet | ||||
122828 | NS 9283 | 913830-15-6 | 98% | |
Coming soon! | ||||
122526 | Nitisinone | 104206-65-7 | 98% | |
Nitisinone is a Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor. | ||||
122513 | Nedaplatin | 95734-82-0 | 98% | |
Nedaplatin is a derivative of cisplatin and DNA damage agent. |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1